Apple Analyst Sees $750 Ahead and 4 Investor Insights Making Rounds

Tetra Tech Inc. (NASDAQ:TTEK): Current price $28.15

Oppenheimer believes that Tetra Tech Inc.’s acquisitions of AEG and Parkland Pipeline leave them poised to accelerate their organic growth. The firm expects both deals to be immediately accretive and they maintain an Outperform rating on the stock.

ttek

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Current price $174.52

Following the recent bullish Eylea survey, which indicated the drug’s uptake trajectory remains strong, Baird raised their price target on Regeneron Pharmaceuticals, Inc. The firm believes the EU roll-out of Eylea and late stage pipeline will push the share price to their price target. Shares are Outperform rated.

regn

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

Xyratex Ltd. (NASDAQ:XRTX): Current price &9.07

After meeting with Xyratex Ltd.’s management, Stifel Nicolaus expects the company’s fundamentals to bottom during the upcoming quarters. The firm disagrees with the view of activist shareholder Baker Street that Xyratex should stop investing in programs focused on future growth, but Stifel thinks Baker Street’s activism increases Xyratex’s valuation visibility. Stifel maintains a Hold rating on the stock.

xrtx

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

Microsoft Corporation (NASDAQ:MSFT): Current price $26.91

Atlantic Equities lowered Microsoft Corporation’s price target due to the weak start to Windows 8. The firm remains Overweight rated due to valuation and reduced expectations.

msft

Apple Inc. (NASDAQ:AAPL): Current price $498.09

Baird believes that weakness in Apple Inc. is a buying opportunity as most demand factors remain favorable. The firm is raising their fourth quarter iPhone forecast slightly and believes that gross margins will benefit from sales of both the iPhone 4 and IPhone 4S. Shares remain Outperform rated with a $750 price target.

aapl

Don’t Miss: Analyst: Apple Worries Not Here to Stay.